28.91 USD
+0.32 (+1.12%)
28.91 USD
0 (0%)
Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 185 industry peers in the Health Care Equipment & Supplies industry. QDEL may be in some trouble as it scores bad on both profitability and health. QDEL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
QDEL had positive earnings in the past year.
QDEL had a positive operating cash flow in the past year.
In multiple years QDEL reported negative net income over the last 5 years.
Each year in the past 5 years QDEL had a positive operating cash flow.
1.2 Ratios
QDEL's Return On Assets of -20.78% is in line compared to the rest of the industry. QDEL outperforms 52.97% of its industry peers.
Looking at the Return On Equity, with a value of -57.90%, QDEL is in line with its industry, outperforming 48.65% of the companies in the same industry.
QDEL's Return On Invested Capital of 1.74% is fine compared to the rest of the industry. QDEL outperforms 67.57% of its industry peers.
QDEL had an Average Return On Invested Capital over the past 3 years of 4.37%. This is below the industry average of 8.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.78% | ||
| ROE | -57.9% | ||
| ROIC | 1.74% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
1.3 Margins
The Operating Margin of QDEL (3.98%) is better than 68.11% of its industry peers.
QDEL's Operating Margin has declined in the last couple of years.
QDEL has a Gross Margin (47.15%) which is in line with its industry peers.
In the last couple of years the Gross Margin of QDEL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.98% | ||
| PM (TTM) | N/A | ||
| GM | 47.15% |
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QDEL is destroying value.
Compared to 1 year ago, QDEL has more shares outstanding
QDEL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for QDEL is higher compared to a year ago.
2.2 Solvency
QDEL has an Altman-Z score of 0.78. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
QDEL has a Altman-Z score (0.78) which is comparable to the rest of the industry.
QDEL has a Debt/Equity ratio of 1.23. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of QDEL (1.23) is worse than 77.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.78 |
ROIC/WACC0.25
WACC7.1%
2.3 Liquidity
A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
QDEL has a Current ratio of 1.78. This is in the lower half of the industry: QDEL underperforms 68.11% of its industry peers.
QDEL has a Quick Ratio of 1.78. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of QDEL (0.98) is worse than 77.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
QDEL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.18%.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -3.67%.
QDEL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.07% yearly.
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%
3.2 Future
The Earnings Per Share is expected to grow by 21.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 1.98% on average over the next years.
EPS Next Y17.21%
EPS Next 2Y20.82%
EPS Next 3Y24.03%
EPS Next 5Y21.56%
Revenue Next Year-2.33%
Revenue Next 2Y0.02%
Revenue Next 3Y1.41%
Revenue Next 5Y1.98%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.62, which indicates a correct valuation of QDEL.
Based on the Price/Earnings ratio, QDEL is valued cheaper than 91.35% of the companies in the same industry.
QDEL is valuated cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.70 indicates a reasonable valuation of QDEL.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 94.05% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of QDEL to the average of the S&P500 Index (24.03), we can say QDEL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.62 | ||
| Fwd PE | 10.7 |
4.2 Price Multiples
94.05% of the companies in the same industry are more expensive than QDEL, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.28 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL's earnings are expected to grow with 24.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y20.82%
EPS Next 3Y24.03%
5. Dividend
5.1 Amount
QDEL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
28.91
+0.32 (+1.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners122.65%
Inst Owner Change3.71%
Ins Owners0.61%
Ins Owner Change1.18%
Market Cap1.96B
Revenue(TTM)2.71B
Net Income(TTM)-1.18B
Analysts74.29
Price Target37.59 (30.02%)
Short Float %17.19%
Short Ratio8.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)-8.24%
PT rev (3m)-16.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-46.16%
EPS NY rev (1m)2.12%
EPS NY rev (3m)-10.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.79%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.62 | ||
| Fwd PE | 10.7 | ||
| P/S | 0.72 | ||
| P/FCF | N/A | ||
| P/OCF | 52.65 | ||
| P/B | 0.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.28 |
EPS(TTM)2.29
EY7.92%
EPS(NY)2.7
Fwd EY9.34%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY1.9%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.73
PEG (5Y)N/A
Graham Number39.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.78% | ||
| ROE | -57.9% | ||
| ROCE | 2.2% | ||
| ROIC | 1.74% | ||
| ROICexc | 1.78% | ||
| ROICexgc | 3.88% | ||
| OM | 3.98% | ||
| PM (TTM) | N/A | ||
| GM | 47.15% | ||
| FCFM | N/A |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexgc growth 3Y-72.1%
ROICexgc growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.57 | ||
| Cap/Depr | 43.31% | ||
| Cap/Sales | 7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 6.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.78 |
F-Score5
WACC7.1%
ROIC/WACC0.25
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
EPS Next Y17.21%
EPS Next 2Y20.82%
EPS Next 3Y24.03%
EPS Next 5Y21.56%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%
Revenue Next Year-2.33%
Revenue Next 2Y0.02%
Revenue Next 3Y1.41%
Revenue Next 5Y1.98%
EBIT growth 1Y4.34%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year938.78%
EBIT Next 3Y132.63%
EBIT Next 5Y90.11%
FCF growth 1Y-203.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.9%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%
QUIDELORTHO CORP / QDEL FAQ
Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?
ChartMill assigns a fundamental rating of 3 / 10 to QDEL.
What is the valuation status of QUIDELORTHO CORP (QDEL) stock?
ChartMill assigns a valuation rating of 6 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Fairly Valued.
What is the profitability of QDEL stock?
QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for QDEL stock?
The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 17.21% in the next year.